Insulin Susp Isophane Recombinant Human Patent Expiration
Insulin Susp Isophane Recombinant Human was first introduced by Eli Lilly And Co
Insulin Susp Isophane Recombinant Human Patents
Given below is the list of patents protecting Insulin Susp Isophane Recombinant Human, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Humulin N | US7291132 | Medication dispensing apparatus with triple screw threads for mechanical advantage |
Aug 09, 2024
(Expired) | Lilly |
Insulin Susp Isophane Recombinant Human's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List